Table 2 Bivariate analysis

Age, n (%)

 ≥ 60 years

12 (85.7)

2 (14.3)

1.125 (0.879–1.439)

0.730

 < 60 years

64 (76.2)

20 (23.8)

Gender, n (%)

 Male

72 (80.9)

17 (19.1)

1.820 (0.867–3.819)

0.025*

 Female

4 (44.4)

5 (55.6)

Diabetes mellitus, n (%)

 Yes

21 (67.7)

10 (32.3)

0.825 (0.631–1.080)

0.126*

 No

55 (82.1)

12 (17.9)

Hypertension, n (%)

 Yes

43 (75.4)

14 (24.6)

0.937 (0.758–1.159)

0.629

 No

33 (80.5)

8 (19.5)

Dyslipidemia, n (%)

 Yes

62 (78.5)

17 (21.5)

1.065(0.794–1.429)

0.760

 No

14 (73.7)

5 (26.3)

Previous ACS, n (%)

 Yes

7 (70.0)

3 (30.0)

0.893 (0.585–1.362)

0.689

 No

69 (78.4)

19 (21.6)

Antiplatelet, n (%)

 Yes

4 (80.0)

1 (20.0)

1.033 (0.656–1.6571)

0.893

 No

72 (77.4)

21 (22.6)

Statin use, n (%)

 No

66 (75.0)

22 (25.0)

0.750 (0.664–0.847)

0.111*

 Yes

10 (100.0)

0 (0.0)

Smoking, n (%)

 Yes

69 (83.1)

14 (16.9)

1.781 (1.025–3.095)

0.004*

 No

7 (46.7)

8 (53.3)

Family history of CAD, n (%)

 Yes

15 (75.0)

5 (25.0)

0.959 (0.725–1.269)

0.768

 No

61 (78.2)

17 (21.8)

Median NLR (IQR)

7.81 (6.38–11.85)

3.38 (2.32–5.43)

N/A

< 0.001^a

NLR

 ≥ 6.42

56 (91.8)

5 (8.2)

1.698 (1.359–2.311)

< 0.001*

 < 6.42

20 (54.1)

17 (45.9)